A Clinical Trial to Evaluate the Effects of a Supplement on Children's Focus and Energy

August 11, 2026 updated by: Auri Nutrition

This study will evaluate the effects of the Auri Super Mushroom Daily Gummies For Kids on focus and energy in children aged 4-12. The study is a single-arm, unblinded, virtual trial conducted over 8 weeks, in which all 35 enrolled participants will use the test product daily.

Parents of the participants will complete questionnaires at Baseline, Week 2, Week 4, Week 6, and Week 8 to assess perceived changes in their child's focus, attention, sleep quality, gut health, natural energy, and overall well-being. Participants will also undergo cognitive battery testing at Baseline, Week 4, and Week 8 to provide objective measurements of focus and cognitive performance.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

35

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Nevada
      • Las Vegas, Nevada, United States, 89101
        • Citruslabs

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Be male or female.
  • Be aged 4-12.
  • Parent(s) reporting that their child has been experiencing issues regarding any of the following for the past four weeks: Difficulty focusing, Poor concentration, or Poor memory.
  • Parent(s) who report that their child will be willing to complete cognitive assessments at regular intervals during the study.
  • Any child who is generally healthy - does not live with any uncontrolled chronic disease.
  • Parent(s) who are willing to follow the study protocol and support their child to complete all study actions.
  • Any child who has no planned changes to school schedule, sleep routines, or behavioral therapies during the study duration.
  • Anyone willing to refrain from introducing any new prescription medications, wellness products, supplements, or herbal remedies into their child's routine during the test period.
  • If the child has been taking any other products, supplements, or herbal remedies, they have been taking these consistently for at least three months.
  • Has had a stable diet and sleep schedule for at least four weeks prior to the study.
  • Enrolled in and currently attending school at baseline and for the duration of the study period.
  • Resides in the United States.

Exclusion Criteria:

  • Any child with a neurodevelopmental condition or developmental delay, including autism spectrum disorder, intellectual disability, language disorder, uncontrolled anxiety or mood disorder, or dyslexia.
  • Previous diagnosis of Attention-deficit hyperactivity disorder (ADHD).
  • Any child currently undergoing any assessments for suspected neurodevelopmental conditions or developmental delay.
  • Any child diagnosed with epilepsy or a seizure disorder.
  • Any child diagnosed with a bleeding disorder.
  • Any child with any known allergies or hypersensitivities to any supplement product ingredients.
  • Any child with any chronic health conditions that could impact their participation in this study, such as cancer, mental health disorders, a history of serious illness in the last three months, or planned surgery during the study period.
  • Any parent or child currently testing, or planning on starting in the next eight weeks, a product for another research study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Auri Super Mushroom Daily Gummies For Kids
Dietary supplement: Auri Super Mushroom Daily Gummies For Kids
All participants receive two Auri Super Mushroom Daily Gummies once daily in the morning with their first meal of the day for 8 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Focus
Time Frame: Baseline, Week 4, and Week 8
Assessed via cognitive battery testing (Polygons, Double Trouble, Feature Match, Paired Associates, Digit Span, Spatial Planning) and self-reported questionnaire
Baseline, Week 4, and Week 8
Change in Cognitive Performance
Time Frame: Baseline, Week 4, and Week 8
Assessed via cognitive battery testing (Polygons, Double Trouble, Feature Match, Paired Associates, Digit Span, Spatial Planning) and self-reported questionnaire
Baseline, Week 4, and Week 8

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Parent-Reported Focus
Time Frame: Baseline, Week 2, Week 4, Week 6, and Week 8
Assessed via parent-completed self-reported questionnaire
Baseline, Week 2, Week 4, Week 6, and Week 8
Change in Parent-Reported Attention
Time Frame: Baseline, Week 2, Week 4, Week 6, and Week 8
Assessed via parent-completed self-reported questionnaire
Baseline, Week 2, Week 4, Week 6, and Week 8
Change in Parent-Reported Sleep Quality
Time Frame: Baseline, Week 2, Week 4, Week 6, and Week 8
Assessed via parent-completed self-reported questionnaire
Baseline, Week 2, Week 4, Week 6, and Week 8
Change in Parent-Reported Gut Health
Time Frame: Baseline, Week 2, Week 4, Week 6, and Week 8
Assessed via parent-completed self-reported questionnaire
Baseline, Week 2, Week 4, Week 6, and Week 8
Change in Parent-Reported Natural Energy
Time Frame: Baseline, Week 2, Week 4, Week 6, and Week 8
Assessed via parent-completed self-reported questionnaire
Baseline, Week 2, Week 4, Week 6, and Week 8
Change in Parent-Reported Overall Well-Being
Time Frame: Baseline, Week 2, Week 4, Week 6, and Week 8
Assessed via parent-completed self-reported questionnaire
Baseline, Week 2, Week 4, Week 6, and Week 8

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Auri Nutrition

Collaborators

Citruslabs

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 13, 2026

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

August 11, 2026

First Submitted That Met QC Criteria

August 11, 2026

First Posted (Actual)

August 14, 2026

Study Record Updates

Last Update Posted (Actual)

August 14, 2026

Last Update Submitted That Met QC Criteria

August 11, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20827
  • legacy-20827

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe